- Home
- Publications
- Publication Search
- Publication Details
Title
Echinocandins in antifungal pharmacotherapy
Authors
Keywords
-
Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 69, Issue 12, Pages 1635-1660
Publisher
Wiley
Online
2017-07-26
DOI
10.1111/jphp.12780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Echinocandins in Ocular Therapeutics
- (2017) Akash Patil et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2016) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants
- (2016) Philipp H. Fesel et al. FUNGAL GENETICS AND BIOLOGY
- Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses
- (2016) Sóstenes Mistro et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Outcome of Candida parapsilosis complex infections treated with caspofungin in children
- (2016) İlker Devrim et al. Mediterranean Journal of Hematology and Infectious Diseases
- Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae
- (2015) Petros Ioannou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rate ofFKSMutations among Consecutive Candida Isolates Causing Bloodstream Infection
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
- (2015) Georg Auzinger et al. BMC INFECTIOUS DISEASES
- Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods
- (2015) Maria Teresa Montagna et al. BMC MICROBIOLOGY
- Echinocandin Resistance in Candida
- (2015) David S. Perlin CLINICAL INFECTIOUS DISEASES
- Dose escalation studies with caspofungin against Candida glabrata
- (2015) Marianna Domán et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Experimental efficacy of anidulafungin againstAspergillus terreusspecies complex
- (2015) Marta Sanchis et al. MEDICAL MYCOLOGY
- Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
- (2014) D.J. Winston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Positions and Numbers ofFKSMutations in Candida albicans Selectively InfluenceIn VitroandIn VivoSusceptibilities to Echinocandin Treatment
- (2014) M. Lackner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
- (2014) Cau D. Pham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT
- (2014) H J Park et al. BONE MARROW TRANSPLANTATION
- Tissue Penetration of Antifungal Agents
- (2014) T. Felton et al. CLINICAL MICROBIOLOGY REVIEWS
- Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC
- (2014) T. Saraya et al. JOURNAL OF CLINICAL MICROBIOLOGY
- New insights into the echinocandins and other fungal non-ribosomal peptides and peptaibiotics
- (2014) Gerald Bills et al. NATURAL PRODUCT REPORTS
- Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization
- (2013) David R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
- (2013) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Transporter Mdr1p-Mediated Uptake of a Novel Antifungal Compound
- (2013) Nuo Sun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Eagle-like effect of echinocandins: what’s in a name?
- (2013) Kim Vanstraelen et al. Expert Review of Anti-Infective Therapy
- Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models
- (2013) Hirohito Kai et al. JOURNAL OF ANTIBIOTICS
- Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study
- (2013) James M. Balkovec et al. NATURAL PRODUCT REPORTS
- Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise
- (2012) Chin Fen Neoh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Innate Immune Receptors in Paradoxical Caspofungin ActivityIn Vivoin Preclinical Aspergillosis
- (2012) Silvia Moretti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant
- (2012) Xiaojun Huang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
- (2012) Michaela Döring et al. BMC INFECTIOUS DISEASES
- Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
- (2012) M. Ruhnke et al. CLINICAL MICROBIOLOGY AND INFECTION
- The postantifungal and paradoxical effects of echinocandins against Candida spp.
- (2012) Brad Moriyama et al. Future Microbiology
- In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis
- (2012) E. Spreghini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The clinical efficacy and safety of micafungin–itraconazole combination therapy in patients with pulmonary aspergilloma
- (2012) Masaki Fujita et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- The Nonsteroidal Antiinflammatory Drug Diclofenac Potentiates the In Vivo Activity of Caspofungin Against Candida albicans Biofilms
- (2012) Anna Bink et al. JOURNAL OF INFECTIOUS DISEASES
- The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates
- (2012) Débora Alves Nunes Mario et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Influence of Fungicidal Activity againstCandida tropicalison the Efficacy of Micafungin and Liposomal Amphotericin B in a Neutropenic Murine Lethal Infection Model
- (2012) Koji Takemoto et al. PHARMACOLOGY
- Total synthesis and structure–activity relationships of caspofungin-like macrocyclic antifungal lipopeptides
- (2012) Jianzhong Yao et al. TETRAHEDRON
- Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
- (2012) Sheena D. Singh-Babak et al. PLoS Pathogens
- Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients
- (2011) Chi-Chung Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigation of the Efficacy of Micafungin in the Treatment of Histoplasmosis Using Two North American Strains of Histoplasma capsulatum
- (2011) Chadi A. Hage et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Effect of Caspofungin against Candida Bloodstream Isolates Is Mediated by Multiple Pathways but Eliminated in Human Serum
- (2011) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species
- (2011) Barbara Fiori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases
- (2011) Oliver A Cornely et al. Expert Opinion On Drug Safety
- Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo
- (2011) Enrique Calvo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
- (2011) R. E. Lewis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis
- (2011) C. F. Neoh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Broth Microdilution and Time–Kill Testing of Caspofungin, Voriconazole, Amphotericin B and their Combinations Against Clinical Isolates of Candida krusei
- (2011) Yasemin Oz et al. MYCOPATHOLOGIA
- Safety of Micafungin in Pediatric Clinical Trials
- (2011) Antonio C. Arrieta et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non-albicans Candida Species: Review of the Caspofungin Database
- (2010) A. L. Colombo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections
- (2010) Elizabeth Gorski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity andIn VivoEfficacy of Anidulafungin in Murine Infections byAspergillus flavus
- (2010) Enrique Calvo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
- (2010) A. H. Groll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated Candidiasis
- (2010) S. Kucharikova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
- (2010) A. J. Zimbeck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transcriptional Regulation of Chitin Synthases by Calcineurin Controls Paradoxical Growth of Aspergillus fumigatus in Response to Caspofungin
- (2010) J. R. Fortwendel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
- (2010) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection
- (2010) J. L. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study
- (2010) Parinda A. Mehta et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry
- (2010) Johan Maertens et al. BMC INFECTIOUS DISEASES
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
- (2010) K. Niimi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interactions between Human Phagocytes andCandida albicansBiofilms Alone and in Combination with Antifungal Agents
- (2010) Aspasia Katragkou et al. JOURNAL OF INFECTIOUS DISEASES
- Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection
- (2010) Susan Julie Howard et al. MEDICAL MYCOLOGY
- Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds
- (2009) M. Cuenca-Estrella et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
- (2009) Jodi M. Lestner et al. CLINICAL INFECTIOUS DISEASES
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit
- (2009) M.A. Ghannoum et al. CLINICAL MICROBIOLOGY AND INFECTION
- Anidulafungin, a New Echinocandin
- (2009) Giulia Morace et al. DRUGS
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Micafungin: a sulfated echinocandin
- (2009) Seiji Hashimoto JOURNAL OF ANTIBIOTICS
- In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Paradoxical echinocandin activity: a limitedin vitrophenomenon?
- (2009) Nathan P. Wiederhold MEDICAL MYCOLOGY
- Actividad antifúngica in vitro de la anidulafungina
- (2009) Guillermo Quindós et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Antifungal Activities of T-2307, a Novel Arylamidine
- (2008) J. Mitsuyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model
- (2008) D. R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany
- (2008) O. A. Cornely et al. CURRENT MEDICAL RESEARCH AND OPINION
- Micafungin activity against Candida albicans with diverse azole resistance phenotypes
- (2008) T. S. Richards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Detection of Caspofungin Resistance in Candida spp. by Etest
- (2008) M. Desnos-Ollivier et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antifungal activity of micafungin againstCandidaandAspergillusspp. isolated from pediatric patients in Japan
- (2008) Fumiaki Ikeda et al. MEDICAL MYCOLOGY
- Commercialization and Late-Stage Development of a Semisynthetic Antifungal API: Anidulafungin/d-Fructose (Eraxis)
- (2008) Timothy Norris et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro
- (2007) Suganthini Krishnan Natesan et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now